Saydah Sharon H, Gregg Edward W, Kahn Henry S, Ali Mohammed K
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, Atlanta, GA, United States.
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, Atlanta, GA, United States.
Prim Care Diabetes. 2018 Feb;12(1):3-12. doi: 10.1016/j.pcd.2017.07.004. Epub 2017 Aug 7.
Determine the mortality experience among adults with diabetes in meeting and not meeting less intense control for glycated hemoglobin (HbA1c), blood pressure (BP), and cholesterol.
National Health and Nutrition Examination Survey 1999-2010 participants with self-report of diagnosed diabetes (N=3335), measured HbA1c, BP and non-HDL cholesterol were linked to the National Death Index through December 31, 2011. Proportional hazards models were used to estimate hazard ratios (HR) of meeting HbA1c<9% and BP<160/110, and non-HDL cholesterol<190mg/dL. Models used age as the time scale and adjusted for demographics (sex, race/ethnicity, education), diabetes duration, history of cardiovascular and chronic kidney disease, and treatments for elevated glucose, BP, and cholesterol.
Over a mean 5.4 person-years of follow-up, participants meeting all less intense control had a 37% lower mortality (HR=0.63, 95% CI 0.54, 0.74) relative to those who did not meet the goals. Of approximately 306,000 deaths per year that occur among Americans with diabetes, we estimate 39,400 might have been averted by improving the care of those who have not met these less intense control goals.
Meeting the less intense control goals is associated with 37% reduction in mortality and could lead to 39,400 fewer deaths per year.
确定糖化血红蛋白(HbA1c)、血压(BP)和胆固醇未达到较低强化控制目标的糖尿病成人患者的死亡情况。
将1999 - 2010年美国国家健康与营养检查调查中自我报告已确诊糖尿病(N = 3335)、测量了HbA1c、血压和非高密度脂蛋白胆固醇的参与者与截至2011年12月31日的国家死亡索引进行关联。使用比例风险模型估计达到HbA1c<9%、血压<160/110以及非高密度脂蛋白胆固醇<190mg/dL的风险比(HR)。模型以年龄作为时间尺度,并针对人口统计学特征(性别、种族/族裔、教育程度)、糖尿病病程、心血管和慢性肾病病史以及血糖、血压和胆固醇升高的治疗情况进行了调整。
在平均5.4人年的随访中,达到所有较低强化控制目标的参与者相对于未达到目标的参与者死亡率降低了37%(HR = 0.63,95%CI 0.54,0.74)。在美国每年约30.6万例糖尿病患者死亡中,我们估计通过改善未达到这些较低强化控制目标者的治疗,可避免39400例死亡。
达到较低强化控制目标可使死亡率降低37%,每年可减少39400例死亡。